Abstract
We have previously shown that in utero nicotine exposure causes impaired fertility, follicle immaturity, and ovarian dysfunction in adult female rat offspring. These characteristics overtly resemble the clinical profile of polycystic ovarian syndrome (PCOS) and recent studies have shown that thiazolidinediones such as rosiglitazone improve fertility in women with PCOS but the mechanism is not well defined. Our goal was to examine whether rosiglitazone would (1) ameliorate the altered ovarian physiology that occurs following fetal and neonatal exposure to nicotine and (2) to examine whether this could be due to normalization of ovarian vascularization. At weaning, offspring of nicotine-exposed dams were given either vehicle (NV) or rosiglitazone (3 mg kg−1 day−1; NR). Offspring of saline-exposed dams received vehicle (SV). Tissues were collected when the female offspring reached 26 weeks of age. NV animals had reduced granulosa cell proliferation and increased ovarian cell apoptosis. Treatment with rosiglitazone increased proliferation, and decreased apoptosis, compared NV animals. NV animals had decreased ovarian vascularity relative to controls, whereas NR animals had an intermediate level of ovarian vessel density. Moreover, ovaries from NV animals had decreased levels of the pro-angiogenic growth factors vascular endothelial growth factor (VEGF) and endocrine gland-derived VEGF both of which were increased with rosiglitazone treatment. Rosiglitazone reversed some of the nicotine effects in the ovary and increased ovarian vascularization, follicle maturation and improved oocyte competence. Rosiglitazone may be an important treatment option for PCOS and the present study provides a potential mechanism by which rosiglitazone may have beneficial effects on fertility in these patients.
Similar content being viewed by others
References
C. Augood, K. Duckitt, A.A. Templeton, Smoking and female infertility: a systematic review and meta-analysis. Hum. Reprod. 13, 1532–1539 (1998)
E.V. Younglai, A.C. Holloway, W.G. Foster, Environmental and occupational factors affecting fertility and IVF success. Hum. Reprod. Update 11, 43–57 (2005)
Practice Committee of the American Society for Reproductive Medicine, Smoking and infertility. Fertil. Steril. 81, 1181–1186 (2004)
M.S. Jensen, L.M. Mabeck, G. Toft, A.M. Thulstrup, J.P. Bonde, Lower sperm counts following prenatal tobacco exposure. Hum. Reprod. 20, 2559–2566 (2005)
T.K. Jensen, T.B. Henriksen, N.H. Hjollund, T. Scheike, H. Kolstad, A. Giwercman, E. Ernst, J.P. Bonde, N.E. Skakkebaek, J. Olsen, Adult and prenatal exposures to tobacco smoke as risk indicators of fertility among 430 Danish couples. Am. J. Epidemiol. 148, 992–997 (1998)
T.K. Jensen, N. Jorgensen, M. Punab, T.B. Haugen, J. Suominen, B. Zilaitiene, A. Horte, A.G. Andersen, E. Carlsen, O. Magnus, V. Matulevicius, I. Nermoen, M. Vierula, N. Keiding, J. Toppari, N.E. Skakkebaek, Association of in utero exposure to maternal smoking with reduced semen quality and testis size in adulthood: a cross-sectional study of 1,770 young men from the general population in five European countries. Am. J. Epidemiol. 159, 49–58 (2004)
L. Storgaard, J.P. Bonde, E. Ernst, M. Spano, C.Y. Andersen, M. Frydenberg, J. Olsen, Does smoking during pregnancy affect sons’ sperm counts? Epidemiology 14, 261–262 (2003)
C.R. Weinberg, A.J. Wilcox, D.D. Baird, Reduced fecundability in women with prenatal exposure to cigarette smoking. Am. J. Epidemiol. 129, 1072–1078 (1989)
J.E. Swauger, T.J. Steichen, P.A. Murphy, S. Kinsler, An analysis of the mainstream smoke chemistry of samples of the U.S. cigarette market acquired between 1995 and 2002. Reg. Toxicol. Pharmacol. 35, 142–156 (2002)
K. Rustemeier, R. Stabbert, H.-J. Haussmann, E. Roemer, E.L. Carmines, Evaluation of the potential effects of ingredients added to cigarettes. Part 2: Chemical composition of mainstream smoke. Food Chem. Toxicol. 40, 93–104 (2002)
C.W. Blackburn, C.A. Peterson, H.A. Hales, D.T. Carrell, K.P. Jones, R.L. Urry, C.M. Peterson, Nicotine, but not cotinine, has a direct toxic effect on ovarian function in the immature gonadotropin-stimulated rat. Reprod. Toxicol. 8, 325–331 (1994)
S.R. Patil, Ravindra, S.R. Patil, R. Londonkar, S.B. Patil, Nicotine induced ovarian and uterine changes in albino mice. Indian J. Physiol. Pharmacol. 42, 503–508 (1998)
A.C. Holloway, L.D. Kellenberger, J.J. Petrik, Fetal and neonatal exposure to nicotine disrupts ovarian function and fertility in adult female rats. Endocrine 30, 213–216 (2006)
M.S. Neal, J. Petrik, W.G. Foster, A.C. Holloway, In utero and lactational exposure to nicotine: ovarian effects. Canadian Fertility and Andrology Society and American Society of Reproductive Medicine, Montreal, PQ, October 2005
N. Ferrara, G. Frantz, J. LeCouter, L. Dillard-Telm, T. Pham, A. Draksharapu, T. Giordano, F. Peale, Differential expression of the angiogenic factor genes vascular endothelial growth factor (VEGF) and endocrine gland-derived VEGF in normal and polycystic human ovaries. Am. J. Pathol. 162, 1881–1893 (2003)
J. Greenaway, K. Connor, H.G. Pedersen, B.L. Coomber, J. LaMarre, J. Petrik, VEGF and its receptor, Flk-1/KDR are cytoprotective in the extravascular compartment of the ovarian follicle. Endocrinology 145, 2896–2905 (2004)
J. Greenaway, P.A. Gentry, J.-J. Feige, J. LaMarre, J. Petrik, Thrombospondin and vascular endothelial growth factor are cyclically expressed in an inverse pattern during bovine ovarian follicle development. Biol. Reprod. 72, 1071–1078 (2005)
J. Greenaway, R. Moorehead, P. Bornstein, J. Lawler, J. LaMarre, J. Petrik, TSP-1 directly inhibits VEGF expression in the ovary through binding and internalization through the low density lipoprotein receptor-related protein-1 (LRP-1). J. Cell Physiol. 210, 807–818 (2007)
P.D. Taylor, H. Wilson, S.G. Hillier, S.J. Weigand, H.M. Fraser, Effects of inhibition of vascular endothelial growth factor at a time of selection on follicular angiogenesis, expansion, development and atresia in the marmoset. Mol. Hum. Reprod. 13, 729–736 (2007)
P.G. Artini, M. Monti, C. Matteucci, V. Valentino, F. Cristello, A.R. Genazzani, Vascular endothelial growth factor and basic fibroblast growth factor in polycystic ovary syndrome during controlled ovarian hyperstimulation. Gynecol. Endocrinol. 22, 465–470 (2006)
P. Froment, P. Touraine, Thiazolidinediones and fertility in polycystic ovary syndrome (PCOS). PPAR Res. 2006, 73986–73994 (2006)
L. George, F. Granath, A.L.V. Johansson, S. Cnattingius, Self-reported nicotine exposure and plasma levels of cotinine in early and late pregnancy. Acta Obstet. Gynecol. Scand. 85, 1331–1337 (2006)
G. Ghazeeri, W.H. Hutteh, M. Bryer-Ash, D. Haas, R.K. We, Effect of rosiglitazone on spontaneous and clomiphene citrate-induced ovulation in women with polycystic ovarian syndrome. Fertil. Steril. 79, 562–566 (2003)
V. Sepilian, M. Nagamani, Effects of rosiglitazone in obese women with polycystic ovary syndrome and severe insulin resistance. J. Clin. Endocrinol. Metab. 90, 60–65 (2005)
J. Petrik, H.C. Gerstein, C. Cesta, A.C. Holloway, Effects of rosiglitazone on ovarian function and fertility following in utero exposure to nicotine. Oral Abstract Canadian Fertility and Andrology Society Meeting, 2007
A.C. Holloway, D.Q. Cuu, K.M. Morrison, H.C. Gerstein, M.A. Tarnopolsky, Transgenerational effects of fetal and neonatal exposure to nicotine. Endocrine 31, 254–259 (2007)
A.C. Holloway, J.J. Petrik, J.E. Bruin, H.C. Gerstein, Rosiglitazone prevents diabetes by increasing beta-cell mass in an animal model of type 2 diabetes characterized by reduced beta cell mass at birth. Diabetes Obes. Metab. 10, 763–771 (2008)
R. Demiralay, N. Gursan, H. Erdem, Regulation of nicotine-induced apoptosis of pulmonary artery endothelial cells by treatment of N-acetylcysteine and vitamin E. Hum. Exp. Toxicol. 26, 595–602 (2007)
R. Machaalani, K.A. Waters, K.D. Tinworth, Effects of postnatal nicotine exposure on apoptotic markers in the developing piglet brain. Neuroscience 132, 325–333 (2005)
M.H. Jang, M.C. Shin, S.B. Jung, T.H. Lee, G.H. Bahn, Y.K. Kwon, E.H. Kim, C.J. Kim, Alcohol and nicotine reduce cell proliferation and enhance apoptosis in dentate gyrus. Neuroreport 13, 1509–1513 (2002)
K.H. Kim, K.J. Joo, H.J. Park, C.H. Kwon, M.H. Jang, C.J. Kim, Nicotine induces apoptosis in TM3 mouse Leydig cells. Fertil. Steril. 83, 1093–1099 (2005)
J.E. Italiano Jr., J.L. Richardson, S. Patel-Hett, E. Battinelli, A. Zaslavasky, S. Short, S. Ryeom, J. Folkman, G.L. Klement, Angiogenesis is regulated by a novel mechanism: pro- and anti-angiogenic proteins are organized into separate platelet alpha granules and differentially released. Blood 111, 12227–12330 (2008)
E.D. Karagiannis, A.S. Popel, Anti-angiogenic peptides identified in Thrombospondin type I domains. Biochem. Biophys. Res. Commun. 359, 63–69 (2007)
R.S. Legro, R.J. Zaino, L.M. Demers, A.R. Kunselman, C.L. Gnatuk, N.I. Wiliams, W.C. Dodson, The effects of metoformin and rosiglitazone, alone and in combination, on the ovary and endometrium in polycystic ovary syndrome. Am. J. Obstet. Gynecol. 196, 402e1–402e10 (2007)
M. Yilmaz, N. Bukan, G. Ayvaz, A. Karakoc, F. Roruner, N. Cakir, M. Arslan, The effects of rosiglitazone and metformin on oxidative stress and homocysteine levels in lean patients with polycystic ovary syndrome. Hum. Reprod. 20, 3333–3340 (2005)
P. Hoffmann, J.J. Feige, N. Alfaidy, Placental expression of E.G-VEGF and its receptors PKR1 (prokineticin receptor-1) and PKR2 throughout mouse gestation. Placenta 28, 1049–1058 (2007)
K. Fuenzalida, R. Quintanilla, P. Ramos, D. Piderit, R.A. Fuentealba, G.R. Martinez, N.C. Inestrosa, M. Bronfman, PPAR gamma up-regulates the Bcl-2 anti-apoptotic protein in neurons and induces mitochondrial stabilization and protection against oxidative stress and apoptosis. J. Biol. Chem. 282, 37006–37015 (2007)
R. Quintana, L. Kopcow, C. Sueldo, G. Marconi, N.G. Rueda, R.I. Baranao, Direct injection of vascular endothelial growth factor into the ovary of mice promotes follicular development. Fertil. Steril. 82, 1101–1105 (2004)
F. Pistrosch, K. Herbrig, U. Oelschlaegel, S. Richter, J. Passauer, S. Fischer, P. Gross, PPARgamma-agonist rosiglitazone increases number and migratory activity of cultured endothelial progenitor cells. Atherosclerosis 183, 163–167 (2005)
C.H. Wang, N. Giliberti, S.H. Li, P.E. Szmitko, R.D. Weisel, P.W. Fedak, M. Al-Omran, W.J. Cherng, R.K. Li, W.L. Stanford, S. Verma, Rosiglitazone facilitates angiogenic progenitor cell differentiation toward endothelial lineage: a new paradigm in glitazone pleiotropy. Circulation 109, 1392–1400 (2004)
Acknowledgements
This work was supported by a research grant from GlaxoSmithKline to ACH and HCG, and the Natural Sciences and Engineering Research Council of Canada and Canadian Institutes for Health Research (JP). Dr. Gerstein holds the Population Health Institute Chair in Diabetes Research (sponsored by Aventis). CEC was funded by a CIHR Strategic Training Program in Tobacco Research Fellowship. We thank Michelle Ross, Ms Sandra Stals and the staff of the McMaster University CAF for their excellent technical assistance.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Petrik, J.J., Gerstein, H.C., Cesta, C.E. et al. Effects of rosiglitazone on ovarian function and fertility in animals with reduced fertility following fetal and neonatal exposure to nicotine. Endocr 36, 281–290 (2009). https://doi.org/10.1007/s12020-009-9229-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-009-9229-4